DEPRENYL (SELEGILINE) IN THE TREATMENT OF PARKINSONS-DISEASE

[1] BERNHEIMER H., 1962, WIENER KLIN WOCHENSCHR, V74, P558

[2] BIRKMAYER W, 1983, MONOAMINE OXIDASE IT, P170

[3] BIRKMAYER W, 1983, PARKINSONS DISEASE

[4] CARLSSON A, 1983, J NEURAL TRANSM S, P19

[5] FORNO LS, 1979, ADV NEUROL, V23, P123

[6] RECEPTOR BASIS FOR DOPAMINERGIC SUPER-SENSITIVITY IN PARKINSONS-DISEASE [J]. NATURE, 1978, 273 (5657) : 59 - 61

[7] LLOYD KG, 1975, J PHARMACOL EXP THER, V195, P453

[8] Oreland L, 1983, Mod Probl Pharmacopsychiatry, V19, P246

[9] RIEDERER P, 1983, ACTA NEUROL SCAND S

[10] [No title captured]

[1] BERNHEIMER H., 1962, WIENER KLIN WOCHENSCHR, V74, P558

[2] BIRKMAYER W, 1983, MONOAMINE OXIDASE IT, P170

[3] BIRKMAYER W, 1983, PARKINSONS DISEASE

[4] CARLSSON A, 1983, J NEURAL TRANSM S, P19

[5] FORNO LS, 1979, ADV NEUROL, V23, P123

[6] RECEPTOR BASIS FOR DOPAMINERGIC SUPER-SENSITIVITY IN PARKINSONS-DISEASE [J]. NATURE, 1978, 273 (5657) : 59 - 61

[7] LLOYD KG, 1975, J PHARMACOL EXP THER, V195, P453

[8] Oreland L, 1983, Mod Probl Pharmacopsychiatry, V19, P246

[9] RIEDERER P, 1983, ACTA NEUROL SCAND S

[10] [No title captured]